PUR-WASH- water solution 
Niagara Pharmaceuticals Inc.

----------

Pur-Wash

Purified Water, 98.3%

Ophthalmic Solution

Eyewash

Drug Facts

Active ingredient

Purified water 98.3%

Purpose

Eyewash

Use

For cleansing the eye to help relieve irritation or burning by removing loose foreign material

Warnings

For external use only

Do not use

  • if you experience any open wounds in or near the eyes and obtain immediate medical treatment
  • if solution changes color or becomes cloudy

When using this product

  • to avoid contamination, do not touch tip of container to any surface
  • do not reuse
  • once opened, discard

Stop use and ask a doctor if you experience

  • changes in vision
  • eye pain
  • condition worsens or persists
  • continued redness or irritation of the eye

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Flush the affected eye as needed, controlling the rate of flow of solution by pressure on the bottle.

Other information

Inactive ingredients

boric acid, sodium borate, sodium chloride

Questions ?

☎ Call 905 690-6277 9 a.m. to 5 p.m. EST Mon-Fri

Manufactured by:
Niagara Pharmaceuticals Inc.
60 Innovation Dr.
Flamborough ON L9H 7P3

PRINCIPAL DISPLAY PANEL - 236 mL Bottle Label

drug facts panel

PUR-WASH 
water solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:65785-162
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
WATER (UNII: 059QF0KO0R) (WATER - UNII:059QF0KO0R) WATER929 g  in 946 mL
Inactive Ingredients
Ingredient NameStrength
BORIC ACID (UNII: R57ZHV85D4)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM BORATE (UNII: 91MBZ8H3QO)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:65785-162-01236 mL in 1 BOTTLE, UNIT-DOSE; Type 0: Not a Combination Product09/12/2011
2NDC:65785-162-02473 mL in 1 BOTTLE, UNIT-DOSE; Type 0: Not a Combination Product09/12/2011
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02230509/12/2011
Labeler - Niagara Pharmaceuticals Inc. (205477792)
Establishment
NameAddressID/FEIBusiness Operations
Niagara Pharmaceuticals Inc.205477792manufacture(65785-162)

Revised: 10/2018
Document Id: 777e1559-7870-8d54-e053-2991aa0aa98d
Set id: 777e1559-786f-8d54-e053-2991aa0aa98d
Version: 1
Effective Time: 20181005
 
Niagara Pharmaceuticals Inc.